ArticleBritish journal of cancer2025

New mechanistic understanding of FXR agonist Vonafexor: inducing sublethal damage of HBV-positive liver cancer cells via promoting anti-tumor immunity.

Banglun Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.